Albeit only at a nominal significance level, ApoA1 also showed consistent inverse association with baseline CKD, incident CKD, and decliner status, suggesting that higher levels of ApoA1 were associated with reduced odds of CKD. Here, APOA1 is linked to chronic kidney disease.